Key result
Three doses of trivalent Sabin vaccine successfully increased group mean antibody titres and induced seroconversion against three types of poliovirus in schoolchildren.
Why the study?
Does three doses of trivalent Sabin vaccine improve antibody titres against poliovirus in schoolchildren?
Cross-Sectional
Does three doses of trivalent Sabin vaccine improve antibody titres against poliovirus in schoolchildren?
Three doses of trivalent Sabin vaccine successfully increased antibody titres and seroconversion against poliovirus in schoolchildren.
Answers are grounded in this paper and cite their sources.
May support polio immunization research in children; hypothesis-generating and should not yet change practice.
The results of a serological survey conducted among schoolchildren during the 1966–1967 immunization campaign against poliomyelitis In the Australian Capital Territory, when three doses of trivalent Sabin vaccine were given, are presented and discussed. Before immunization with Sabin vaccine commenced, most individuals studied had antibody against Type 2 virus. However, an appreciable proportion of children, particularly among those aged five to 10 years, had little or no antibody against Type 1 or Type 3 poliovirus. Some children without detectable antibody to either Type 1 or Type 3 virus were present among those who had received four injections of Salk vaccine. In this category, the proportions of children aged five to 10 years who had antibody titres of less than 1:4 were 5% for Type 1 and 15% for Type 3. The significance of these findings Is discussed, and it is suggested that further Immunization against poliomyelitis was desirable in this community. That the Sabin immunization campaign was successful is shown by the increase in group mean antibody titres against the three types of poliovirus, by the seroconversion of those subjects previously lacking antibody and by the increase of antibody titres in a high proportion of the Individuals studied. As most antibody responses occurred after the first dose of Sabin vaccine, and almost all of the remainder after the second dose, the composition of the vaccine used appears satisfactory.
No takes yet. Share an insight, caveat, or question.
Withell et al. (1970) conducted a cross-sectional in Poliomyelitis. Trivalent Sabin vaccine was evaluated on Antibody titres against Type 1, 2, and 3 poliovirus. Three doses of trivalent Sabin vaccine successfully increased group mean antibody titres and induced seroconversion against three types of poliovirus in schoolchildren.
Synapse has enriched 10 related papers. Consider them for comparative context: